Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 2011 Jan;57(1):42–44.

Reducing inappropriate antibiotic use among children with influenza infection

Bat-Chen Friedman, Derek Schwabe-Warf, Ran Goldman
PMCID: PMC3024158  PMID: 21252129

Abstract

Question With the influenza season reaching a peak, I see numerous children in my clinic with fever and influenza-like illnesses. Parents are concerned and at times ask for antibiotic treatment in hopes that the treatment will shorten the duration of illness. What strategies can I use in order to minimize inappropriate prescription of antibiotics during the influenza season?

Answer Use of antibiotics for treatment of viral infections such as influenza contributes to the emergence of resistant bacteria strains. Misuse and overuse of antibiotics can be reduced by preventing the infection and its complications through vaccination, point-of-care rapid influenza testing, and early antiviral treatment when appropriate, as well as constantly increasing the knowledge of both physicians and families regarding the appropriate use of antibiotics.


Antibiotic resistance to pathogenic bacteria in the community setting has been identified as an emerging threat to public health. For example, 20% to 33% of Streptococcus pneumonia isolates are no longer susceptible to penicillin.1,2 Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage in children has increased dramatically in the past decade. In 2001, data from a large pediatric primary care practice in the United States demonstrated colonization rates of 0.8%. In 2005, a repeat survey in the same pediatric primary care practice found that MRSA nasal carriage exceeded 9%.3 During the same period of time, nasal carriage of MRSA was reported to be as high as 22% among children admitted to a pediatric hospital in Texas.4 As the rate of MRSA nasal carriage increases, there is a potential for increased co-infection with influenza virus, resulting in severe morbidity and potential mortality in children.5

An important factor in the development of antibiotic resistance is overuse of antibiotics.6 Of particular concern is overprescription of antibiotics for the treatment of viral upper respiratory infections and influenza-like illnesses.7 The results of a nationwide US survey published in 2004 showed 38% of more than 6.5 million visits (primary practice, outpatient, and emergency department) by children and adults with a sole diagnosis of influenza were associated with antibiotic prescriptions.8 Studies limited to children demonstrated even higher rates of antibiotic treatment in children diagnosed with viral infections.9 Minimizing antibiotics on a national scale can reduce resistance rates. This goal might be achieved by better use of diagnostic tests and antiviral treatment and by enhancing physician and patient education.

Diagnostic strategies

One of the prime factors leading to inappropriate prescription of antibiotics for children with influenza infection is the difficulty in making a reliable and rapid clinical diagnosis. Cough and fever are the most common symptoms, but influenza infection can have an atypical presentation, especially in children, and no single symptom can confirm or exclude influenza.10 The main challenge for physicians is distinguishing between the clinical features of influenza and bacterial infections. Laboratory tests such as complete blood count and C-reactive protein measurement might help recognize bacterial involvement but they are not readily available in most community settings. There are several diagnostic tests for influenza. Viral culture and reverse transcription polymerase chain reaction are the criterion standards for diagnosis, but both methods are time-consuming, expensive, and require specialized laboratory facilities.11 Rapid tests based on immunoassays or neuraminidase activity can detect influenza A and B viruses within 30 minutes. They are of variable sensitivity (median 70% to 75%) and high specificity (median 90% to 95%).12 Significant false-negative rates were documented during times of high influenza prevalence.13 Nevertheless, by providing additional support for the initial clinical diagnosis, these assays promote the rational use of antiviral agents and discourage the inappropriate prescribing of antibiotics.14,15 Given time, cost, and accuracy constraints, rapid testing is the most common and practical way to test for influenza, and has the potential to reduce inappropriate antibiotic use and laboratory tests associated with influenza-like illness in up to 50% of cases.15

Vaccinations and antiviral therapy

Preventive measures such as hand washing and vaccination are the most efficient and cost-effective ways to reduce the incidence of infection thus preventing the use of inappropriate antibiotics.16,17 Expanding vaccination guidelines to infants (aged 6 months or older) can improve antibiotic use for treatment of suspected secondary bacterial infections in young children. Use of live virus vaccines, which have 15% to 20% higher efficacy than inactivated vaccines, could further reduce the burden of influenza.16

Antiviral medications as post-exposure therapy or after confirming influenza have been shown to reduce the duration of infection and, when used as recommended, they can potentially reduce the demand for antibiotic treatment.18 Nevertheless, wide use of antiviral treatment is still controversial.

Physician and parent education

Physicians might overprescribe antibiotics as a response to parents’ expectations. A survey of more than 600 practising pediatricians found that 96% had been asked by parents for antibiotics when they were unnecessary. One-third of doctors reported providing the medications, even though they were not indicated.19 Under pressure, especially during winter months, physicians might lack the time necessary to explain why antibiotics have no clinical effect on viral infections. Patient education programs can reduce the direct and indirect pressures on doctors to prescribe antibiotics. When these programs have targeted those who receive antibiotics most frequently, they have proven successful in reducing patient uncertainty about the necessity of antibiotics.20 A study by Hemo et al demonstrated how a nationwide campaign based on television programming was an effective way to impart knowledge regarding antibiotic use. Antibiotic purchases following upper respiratory infection diagnosis during the postintervention period decreased compared with the parallel baseline period (odds ratio 0.75). A substantial reduction in antibiotic purchasing was also demonstrated for diagnosed otitis media (odds ratio 0.65).21 Physician education can also contribute to appropriate antibiotic use; however, changing physician behaviour is a complex task and educational strategies do not always accomplish the desired results.22

Conclusion

Misuse of antibiotic treatment of influenza infections and the subsequent emergence of bacterial resistance can be reduced by limiting viral spread through hand hygiene and vaccination, using point-of-care rapid influenza tests, judicious use of antiviral medications, and expanding the knowledge of physicians and parents regarding appropriate use of antibiotics.

PRETx

Child Health Update is produced by the Pediatric Research in Emergency Therapeutics (PRETx) program (www.pretx.org) at the BC Children’s Hospital in Vancouver, BC. Dr Friedman and Mr Schwabe-Warf are members and Dr Goldman is Director of the PRETx program. The mission of the PRETx program is to promote child health through evidence-based research in therapeutics in pediatric emergency medicine.

Do you have questions about the effects of drugs, chemicals, radiation, or infections in children? We invite you to submit them to the PRETx program by fax at 604 875-2414; they will be addressed in future Child Health Updates. Published Child Health Updates are available on the Canadian Family Physician website (www.cfp.ca).

Footnotes

Competing interests

None declared

References

  • 1.Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumonia in the United States. N Engl J Med. 2000;343(26):1917–24. doi: 10.1056/NEJM200012283432603. [DOI] [PubMed] [Google Scholar]
  • 2.Finkelstein JA, Huang SS, Daniel J, Rifas-Shiman SL, Kleinman K, Goldmann D, et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multi-community sample. Pediatrics. 2003;112(4):862–9. doi: 10.1542/peds.112.4.862. [DOI] [PubMed] [Google Scholar]
  • 3.Creech CB, 2nd, Kernodle DS, Alsentzer A, Wilson C, Edwards KM. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J. 2005;24(7):617–21. doi: 10.1097/01.inf.0000168746.62226.a4. [DOI] [PubMed] [Google Scholar]
  • 4.Alfaro C, Mascher-Denen M, Fergie J, Purcell K. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in patients admitted to Driscoll Children’s Hospital. Pediatr Infect Dis J. 2006;25(5):459–61. doi: 10.1097/01.inf.0000215228.25382.bd. [DOI] [PubMed] [Google Scholar]
  • 5.Finelli L, Fiore A, Dhara R, Brammer L, Shay DK, Kamimoto L, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics. 2008;122(4):805–11. doi: 10.1542/peds.2008-1336. [DOI] [PubMed] [Google Scholar]
  • 6.Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992;257(5073):1050–5. doi: 10.1126/science.257.5073.1050. [DOI] [PubMed] [Google Scholar]
  • 7.McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287(23):3096–102. doi: 10.1001/jama.287.23.3096. [DOI] [PubMed] [Google Scholar]
  • 8.Ciesla G, Leader S, Stoddard J. Antibiotic prescribing rates in the US ambulatory care setting for patients diagnosed with influenza, 1997–2001. Respir Med. 2004;98(11):1093–101. doi: 10.1016/j.rmed.2004.03.021. [DOI] [PubMed] [Google Scholar]
  • 9.Wilkes JJ, Leckerman K, Coffin SE, Keren R, Metigan TA, Hodinka LR, et al. Use of antibiotics in children hospitalized with community-acquired, laboratory-confirmed influenza. J Pediatr. 2009;154(3):447–9. doi: 10.1016/j.jpeds.2008.09.026. [DOI] [PubMed] [Google Scholar]
  • 10.Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza? JAMA. 2005;293(8):987–97. doi: 10.1001/jama.293.8.987. [DOI] [PubMed] [Google Scholar]
  • 11.Harper SA, Bradley JS, Englund JA, File TM, Gravenstain S, Hayden FG, et al. Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis and institutional outbreak management: clinical practice guidelines of the Infectious Disease Society of America. Clin Infect Dis. 2009;48(8):1003–32. doi: 10.1086/604670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.World Health Organization [website] WHO recommendations on the use of rapid testing for influenza diagnosis. Geneva, Switz: World Health Organization; 2005. Available from: www.who.int/csr/disease/avian_influenza/guidelines/rapid_testing. Accessed 2010 Nov 15. [Google Scholar]
  • 13.Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment of influenza. Pediatr Infect Dis J. 2003;22(2):164–77. doi: 10.1097/01.inf.0000050458.35010.b6. [DOI] [PubMed] [Google Scholar]
  • 14.Jennings LC, Skopnik H, Burckhardt I, Hribar I, Del Piero L, Deichmann KA. Effect of rapid influenza testing on the clinical management of paediatric influenza. Influenza Other Respi Viruses. 2009;3(3):91–8. doi: 10.1111/j.1750-2659.2009.00079.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics. 2003;112(2):363–7. doi: 10.1542/peds.112.2.363. [DOI] [PubMed] [Google Scholar]
  • 16.Manzoli L, Schioppa F, Boccia A, Villari P. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J. 2007;26(2):97–106. doi: 10.1097/01.inf.0000253053.01151.bd. [DOI] [PubMed] [Google Scholar]
  • 17.Grayson ML, Melvani S, Druce J, Barr IG, Ballard SA, Johnson PD, et al. Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin Infect Dis. 2009;48(3):285–91. doi: 10.1086/595845. [DOI] [PubMed] [Google Scholar]
  • 18.Low D. Reducing antibiotic use in influenza: challenges and rewards. Clin Microbiol Infect. 2008;14(4):298–306. doi: 10.1111/j.1469-0691.2007.01910.x. Epub 2007 Dec 18. [DOI] [PubMed] [Google Scholar]
  • 19.Bauchner H, Pelton SI, Klein JO. Parents, physicians, and antibiotic use. Pediatrics. 1999;103(2):395–401. doi: 10.1542/peds.103.2.395. [DOI] [PubMed] [Google Scholar]
  • 20.De Marco G, Mangani S, Correra A, Di Caro S, Tarallo L, De Franciscis A, et al. Reduction of inappropriate hospital admissions of children with influenza-like illness through the implementation of specific guidelines: a case-controlled study. Pediatrics. 2005;116(4):506–11. doi: 10.1542/peds.2005-0053. [DOI] [PubMed] [Google Scholar]
  • 21.Hemo B, Shamir-Shtein NH, Silverman BG, Tsamir J, Heymann AD, Tsehori S, et al. Can a nationwide media campaign affect antibiotic use? Am J Manag Care. 2009;15(8):529–34. [PubMed] [Google Scholar]
  • 22.Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA. 1995;274(9):700–5. doi: 10.1001/jama.274.9.700. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES